Scholars Central

Review articlePublished 15 Jul 2016

Biopharmaceutical protein production by Saccharomyces cerevisiae: current state and future prospects

Authors: Mingtao Huang, Jichen Bao, Jens Nielsen

Pharmaceutical Bioprocessing

Volume 2 · Issue 2 · Pages 167–182

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the past few decades there has been an increasing demand of biopharmaceutical proteins in the market. Several types of cell factories are applied to produce different pharmaceutical proteins. However, manufacturers prefer to use a few favorable biological platforms to undertake the production tasks with low cost, high productivity and proper post-translational modifications. The yeast Saccharomyces cerevisiae is one of these preferred cell factories as it meets many of the requirements. There are several reports on improvement of recombinant protein production by S. cerevisiae through rational engineering of different stages of the protein secretion pathway. However, recent developments of new technologies like systems biology and synthetic biology open new doors to design S. cerevisiae as an ideal production platform.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Bioprocessing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Bioprocessing
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Mingtao Huang”
  • BylineArticles whose byline prints “Jichen Bao”
  • BylineArticles whose byline prints “Jens Nielsen”